Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update

Eli Lilly Alzheimer's drug rejected by EU regulator

Ruchika Sharma31 March 2025 5:20 PM IST

Indianapolis: Indianapolis-based pharmaceutical giant Eli Lilly has faced a setback as the European Union's drug regulator rejected its...

KKR divests 5.8 percent stake in JB Chemicals & Pharma for Rs 1460 crore

Ruchika Sharma31 March 2025 4:44 PM IST

New Delhi: KKR, the U.S.-based private equity giant, has divested a 5.8 per cent stake in JB Chemicals & Pharmaceuticals for Rs 1,460 crore...

USFDA top vaccine official Peter Marks forced out

Ruchika Sharma31 March 2025 4:15 PM IST

Bengaluru: Peter Marks, the top vaccine official at the U.S. Food and Drug Administration (USFDA) has been pushed out of his role, the Wall Street...

Novartis appoints Karen Hale as Chief Legal and Compliance Officer

Ruchika Sharma31 March 2025 2:55 PM IST

Basel: Novartis has announced the appointment of Karen Hale to the expanded role of Chief Legal and Compliance Officer for Novartis, effective...

Sun Pharma Advanced Research Company incorporates wholly owned subsidiary Genokine Biotech

Sun Pharma Advanced Research Company submits IND application for SBO-154 to USFDA

Ruchika Sharma31 March 2025 1:09 PM IST

Mumbai: Sun Pharma Advanced Research Company Ltd. has announced submission of an Investigational New Drug (IND) application with the US...

Panacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant Library

Panacea Biotec: Manjula Upadhyay ceases to be Independent Director, Chairperson/member of Committees of Board of Directors

Ruchika Sharma31 March 2025 11:30 AM IST

New Delhi: Panacea Biotec Limited has announced that Manjula Upadhyay, Independent Director of the Company, has completed her second and...

Medicines worth Rs 6,975 crore in MRP terms sold through JAKs in last 10 years

Ruchika Sharma30 March 2025 2:15 PM IST

New Delhi: Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme, quality generic medicines are being made available through a network of over...

Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment

Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1

Ruchika Sharma30 March 2025 12:15 PM IST

Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Sanofi Dupixent approved in Japan for COPD

Ruchika Sharma30 March 2025 10:00 AM IST

Dupixent is intended for injection under the skin (subcutaneous injection) and is given every other week.

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb gets Positive EMA Committee opinion for subcutaneous formulation of Opdivo across Multiple Solid Tumor Indications

Ruchika Sharma29 March 2025 5:47 PM IST

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: Report

AstraZeneca Pharma India to discontinue manufacturing, marketing of angina drug from April 1

Ruchika Sharma29 March 2025 2:21 PM IST

Bangalore: AstraZeneca Pharma India Limited has announced that the Company will be discontinuing the manufacturing and marketing of the product...

Novartis eyes Avidity Biosciences in potential takeover: Report

Novartis radioligand therapy Pluvicto gets USFDA nod for expanded indication

Ruchika Sharma29 March 2025 1:15 PM IST

Basel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok